- Went public, Jun 2021
- Raised $50M funding round led by General Electric, May 2022
- Raised $7.5M funding round, Jun 2026
About
Pulsenmore has developed a reliable, universally accessible home ultrasound device for remote care. Its technology enables patients to self-scan by connecting their own smartphone to a novel handheld ultrasound cradle. Scans are automatically sent for remote clinical assessment by healthcare providers. Pulsenmores at-home prenatal ultrasound for remote assessment of fetal well-being empowers women to proactively manage their pregnancies in collaboration with their healthcare providers. The technology aims to enhance the availability of care, improve resource management, and increase patient satisfaction. The Pulsenmore home ultrasound system for fetal monitoring has CE and AMAR certification and is commercially available across Europe and Israel; in the U.S. the system is limited under federal law to investigational use only.
Funding history · 5 rounds · $118.3M total
Q&A
- What is Pulsenmore's primary product?
- Pulsenmore has developed a handheld ultrasound device that connects to a smartphone, enabling patients to self-scan for remote clinical assessment by healthcare providers.
- When did Pulsenmore go public on the TASE?
- Pulsenmore became public on the TASE in June 2021, raising $40,000,000 through its IPO.
- Which investor participated in Pulsenmore's May 2022 funding round?
- In May 2022, General Electric invested $50,000,000 in Pulsenmore.
- What is the status of Pulsenmore's home ultrasound system in the U.S.?
- In the U.S., Pulsenmore's home ultrasound system for fetal monitoring is limited to investigational use only, though it has CE and AMAR certification and is commercially available across Europe and Israel.
- What was a significant development for Pulsenmore in November 2025 regarding the U.S. market?
- In November 2025, Pulsenmore received FDA De Novo Marketing Authorization for its home-use prenatal ultrasound, pioneering a new era of prenatal care in the U.S.
- What is Pulsenmore's employee count?
- Pulsenmore has 59 employees, falling within the 51-200 employee bucket.
- What strategic partnership did Pulsenmore announce in June 2026?
- In June 2026, Pulsenmore announced a strategic partnership with Ouma Health to expand access to remote prenatal care across the United States.
- What was Pulsenmore's total funding raised to date?
- Pulsenmore has raised a total of $118,296,458 in funding.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | pulsenmore.com/contact |
|---|---|
| linkedin.com/company/73240861 | |
| facebook.com/Pulsenmore | |
| YouTube | youtube.com/channel/UCwRd9V21x0LXVgdNRK9sAGg |
| instagram.com/pulsenmore_home_ultrasound/ |
Identifiers & details
| Founded | 2014-10 |
|---|---|
| Employees (exact) | 59 |
| Offices | Boston; Omer; Ramat Gan |
| Market cap | $344.9M |
| Status reason | Public on TASE on Jun, 2021; |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2021-06 | $40.0M |
Radar intelligence
Patents
| EPO | 23 |
|---|
Publications (Crossref)
| Works | 2 |
|---|
Web history (Wayback)
| Domain | pulsenmore.com |
|---|